Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Press Releases

Press Releases

139 results

Filter Results By

Filter Applied. Clear All

Latest Posts

June 18, 2024 Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion June 3, 2024 Abortion Reporting: Arkansas (2023) Abortion Reporting: Arkansas (2023) May 29, 2024 Abortion Reporting: West Virginia (2023) Abortion Reporting: West Virginia (2023)
Reset All Filters
139 results
featured-image
Press Releases

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to remove medical safeguards and in-person administering of abortion drugs. These flaws illustrate the ongoing problem of lack of quality abortion reporting data in the U.S. as well as in the United Kingdom.

charlotte-lozier-institute Charlotte Lozier Institute
May 13, 2024
ClosePlease login
featured-image
Press Releases

New Study: Abortion Increases Risk of Cardiovascular Diseases

A new longitudinal peer-reviewed study by the Charlotte Lozier Institute has shown that abortions are an independent risk factor for increased risk of cardiovascular diseases (CVD), the leading cause of death among women.

featured-image
Press Releases

Scientists to SCOTUS: FDA Harms Women & Doctors by Allowing Dangerous Mail-Order Abortion Drugs

As the nation’s leading pro-life scientific, statistical and research center, the Charlotte Lozier Institute has filed an amicus brief asking the Supreme Court to affirm the 5th U.S. Circuit Court of Appeals decision that found the FDA likely violated the law when it loosened safeguards on abortion drugs by allowing them to be sent by mail.

featured-image
Press Releases

Leading Pro-Life Research Group Welcomes New Executive Director

The Charlotte Lozier Institute, the nation's premier research and education institute on pro-life issues, welcomes its new executive director, Karen M. Czarnecki, a seasoned non-profit and government leader.

featured-image
Press Releases

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

On February 19, 2024, CLI associate scholar Mary E. Harned, J.D., submitted an amicus brief on behalf of CLI to the Constitutional Court of Ecuador. This brief was written in support of three provisions of Ecuador’s Organic Law Regulating the Voluntary Interruption of Pregnancy: (1) a requirement that ultrasounds be performed prior to abortion decisions, (2) a 12-week gestational age limit on abortion, and (3) a prohibition on the commodification of post-abortion fetal remains. Following is CLI’s amicus brief reproduced in full.

Press Releases

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

On January 25, 2024, CLI submitted a public comment to the CDC regarding newly proposed modifications related to data collection and reporting from assisted reproductive technology programs and modifications to data validation procedures. In light of the fact that none of these proposed changes recognized the inherent value and dignity of nascent human beings created from ART programs, including IVF, CLI took the opportunity to encourage the CDC to do so and to consider limiting, reporting, or regulating "the number of living embryos destined for research and destruction."

featured-image
Press Releases

CLI Scholars React to Nature Medicine Study

Following the release of a study in Nature Medicine, which discussed the “safety and effectiveness” of abortion drugs acquired through telehealth, Tessa Longbons Cox, senior research associate at the Charlotte Lozier Institute, made the following statement:

featured-image
Press Releases

Charlotte Lozier Institute Responses to Sage Retractions

The Charlotte Lozier Institute (CLI) and associate scholars are facing an unprecedented attack on our research. We believe that because our research has been widely read and cited, including in prominent legal contexts, we are now subject to unprovoked and partisan assault. Sage Publishing, an academic publishing company, retracted three of our studies on February 5, 2024. This action is meritless because, among other things, Sage to this day has advanced no legitimate objection to any findings of the studies.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image